Acarbose and Somatrogon-Ghla: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Acarbose
Somatrogon-Ghla
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. You take acarbose to help keep your blood sugar down after meals. Somatrogon-ghla is a growth hormone, and growth hormone can make your body less sensitive to insulin, especially at higher doses. In plain terms, this can push your blood sugar higher and work against what your acarbose is doing.
The good news is this is very manageable. Your care team can check your blood sugar more often and fine-tune your diabetes medicine as needed. Please keep taking both exactly as prescribed, and let your pharmacist or doctor know if your sugar readings start creeping up.
Effect: Somatrogon-ghla (growth hormone) can reduce insulin sensitivity, producing a pharmacodynamic antagonism of acarbose's glucose-lowering effect and risking worsened hyperglycemia. This is dose-related, more pronounced at higher GH doses.
- Mechanism: GH-induced insulin resistance (exact mechanism unspecified); not a CYP/transporter interaction. Neither agent is metabolically activated in a way that changes direction.
- Evidence: Probable; severity major. Onset unspecified.
- Management: Adjust antidiabetic dosing when initiating somatrogon-ghla. Monitor glucose periodically, especially with diabetes risk factors (obesity, Turner syndrome, family history). New-onset type 2 diabetes has been reported with GH therapy.
What happens
Reduced insulin sensitivity
Interaction Deep Dive
When somatrogon-ghla therapy is started, the dosing of antidiabetic medications should be modified. As a growth hormone, somatrogon-ghla can reduce insulin sensitivity, an effect that is more pronounced at elevated doses. All patients taking somatrogon-ghla should have their glucose measured at regular intervals, with particular attention to individuals who carry diabetes mellitus risk factors, including obesity, Turner syndrome, or a family history of diabetes mellitus. Cases of newly developed type 2 diabetes mellitus have occurred in patients treated with growth hormone1.
Why it happens (mechanism)
Unknown
How to manage this interaction
This can be managed with monitoring and dose tailoring. Because growth hormone can raise blood sugar, your acarbose (and any other diabetes medicine) may need to be adjusted and individualized by your care team when somatrogon-ghla is started.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Expect your team to check your blood sugar periodically, especially if you have diabetes risk factors like obesity, Turner syndrome, or a family history of diabetes.
- Report rising blood sugar readings, increased thirst, or frequent urination to your pharmacist or doctor.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) The onset of new type 2 diabetes mellitus has been documented in patients treated with growth hormone 1.
Common questions
Can I take Acarbose and Somatrogon-Ghla together?
Somatrogon-ghla can raise blood sugar and work against acarbose, so your care team may check your glucose more often and adjust your diabetes medicine. Keep taking both as prescribed and report any rising readings. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Acarbose and Somatrogon-Ghla interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Acarbose and Somatrogon-Ghla interaction managed?
This can be managed with monitoring and dose tailoring. Because growth hormone can raise blood sugar, your acarbose (and any other diabetes medicine) may need to be adjusted and individualized by your care team when somatrogon-ghla is started. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Expect your team to check your blood sugar periodically, especially if… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Acarbose or Somatrogon-Ghla need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: NGENLA subcutaneous solution, somatrogon-ghla subcutaneous solution. Pfizer Labs (per FDA), New York, NY, 2023. DailyMed
Keep reading about Acarbose
Keep reading about Somatrogon-Ghla
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist